skip to content
   

The principals of THE SAGE GROUP may own stock in the companies included in the research reports.

At the end of the fourth quarter 2016 we owned the following securities:

Abbott Laboratories, Inc.

AbbVie Inc.

Angiodynamics Inc.

Derma Sciences Inc

According to
THE SAGE GROUP :

PAD is not just a leg problem. PAD is a marker for severe systemic atherosclerosis as evidenced by the high morbidity and mortality.

Research has shown that within 5 years approximately 50% will experience a cardiovascular event (defined as a heart attack or stroke) and 30% of these will be fatal.

This 5-year mortality rate is higher than that of breast cancer or coronary artery disease.

(Volume I and Volume II)

 

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development